Understanding bare-metal vs drug-eluting stents is a common question for patients preparing for a coronary intervention, since both device types remain part of modern interventional cardiology practice. While they share the same basic structural purpose, holding open a narrowed artery, they differ meaningfully in coating, mechanism, and the clinical scenarios where each may be considered. This comparison is educational in nature; the choice between stent types is always made by the treating cardiologist.
What Is a Bare-Metal Stent?
A bare-metal stent (BMS) is a metal mesh scaffold, typically made from stainless steel or cobalt-chromium alloys, without any drug coating. It works purely as a mechanical support structure.
- Provides immediate mechanical scaffolding to hold the artery open
- Does not release medication into the surrounding tissue
- Historically associated with somewhat higher rates of in-stent restenosis compared to drug-eluting alternatives
- May be considered in specific clinical situations, such as when a shorter duration of antiplatelet therapy is preferred
What Is a Drug-Eluting Stent?
A drug-eluting stent (DES) shares the same mechanical scaffold function but includes a coating that releases a controlled dose of medication, such as sirolimus, into the vessel wall over time.
- Designed to reduce excessive tissue growth (neointimal hyperplasia) that contributes to restenosis
- Coating and drug dose vary by manufacturer and platform; for example, the INVAMED ATLAS drug-eluting stent uses a cobalt-chromium L605 frame with a sirolimus coating at 1 µg/mm²
- Generally requires a defined period of dual antiplatelet therapy, as determined by the prescribing physician, to support vessel healing around the device
How Do the Two Stent Types Compare?
| Feature | Bare-Metal Stent | Drug-Eluting Stent |
|---|---|---|
| Drug coating | None | Anti-proliferative coating (e.g., sirolimus) |
| Mechanism | Mechanical scaffolding only | Mechanical scaffolding plus localized drug release |
| Restenosis considerations | Historically higher relative rates | Designed to reduce restenosis risk |
| Antiplatelet therapy | Physician-determined duration | Physician-determined duration, often longer |
| Typical alloy options | Stainless steel or cobalt-chromium | Frequently cobalt-chromium for thinner struts |
This table reflects general design characteristics; actual clinical performance depends on lesion type, patient factors, and adherence to prescribed medication.
How Do Physicians Decide Which Type to Use?
The choice between a bare-metal and drug-eluting stent depends on multiple individualized factors that only a cardiologist can properly weigh, including:
- The patient's bleeding risk and ability to safely complete a course of antiplatelet therapy
- Anticipated need for other surgeries or procedures in the near future that might require pausing antiplatelet medication
- Lesion characteristics and vessel size
- The urgency and clinical context of the procedure
Neither stent type is universally "better"; each has a role depending on the clinical picture, and this determination is made by the treating physician.
Frequently Asked Questions
Are drug-eluting stents always preferred over bare-metal stents?
Not necessarily. While drug-eluting stents are commonly used in contemporary practice for many patients, bare-metal stents remain a relevant option in select clinical circumstances, such as when a shorter antiplatelet therapy duration is medically preferable. The decision is individualized.
Do both stent types require blood-thinning medication afterward?
Yes, physicians typically prescribe antiplatelet therapy after placement of either stent type to reduce the risk of clot formation while the vessel heals, though the recommended duration may differ. Only the prescribing physician can determine the appropriate regimen for an individual patient.
Is one stent type safer than the other?
Both stent types are used in clinical practice and carry their own considerations and risks, as with any implanted medical device. Neither type can be described as risk-free, and appropriateness depends on the individual patient's clinical situation as assessed by a cardiologist.
Related INVAMED Resources
- ATLAS Drug Eluting Coronary Stent System Cobalt Chromium
- Atlas Coronary Stent System Stainless Steel
- Coronary Artery Disease & Cardiac Interventions
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.